Solute control by extracorporeal therapies in acute renal failure

William R. Clark, Bruce A. Mueller, Michael A. Kraus, William L. Macias

Research output: Contribution to journalArticle

12 Scopus citations


A clear relationship between dialysis dose and outcome in chronic hemodialysis patients has been demonstrated. Recent data suggest renal replacement therapy (RRT) dose or intensity may affect outcome in critically ill acute renal failure (ARF) patients also. This review addresses the factors influencing small solute removal by extracorporeal RRTs in ARF. Methods to quantify and compare small solute removal by intermittent and continuous therapies in ARF are also presented. Finally, studies demonstrating a link between therapy intensity and outcome are assessed. To improve the management of critically ill ARF patients, the effect of delivered RRT dose on ARF outcome requires additional analysis.

Original languageEnglish (US)
Pages (from-to)S21-S27
JournalAmerican Journal of Kidney Diseases
Issue number5 SUPPL. 3
StatePublished - Nov 1996


  • Hemodialysis
  • clearance
  • hemofiltration
  • solute

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Solute control by extracorporeal therapies in acute renal failure'. Together they form a unique fingerprint.

  • Cite this

    Clark, W. R., Mueller, B. A., Kraus, M. A., & Macias, W. L. (1996). Solute control by extracorporeal therapies in acute renal failure. American Journal of Kidney Diseases, 28(5 SUPPL. 3), S21-S27.